Trends in pediatric nonprescription analgesic/antipyretic exposures during the COVID-19 pandemic.
Sara KaramiCooma AsonyeEllen PinnowValerie PrattLynda McCulleyNana DwumfourEsther H ZhouPublished in: Clinical toxicology (Philadelphia, Pa.) (2023)
Nonprescription analgesic/antipyretic unintentional exposure cases declined among young children, while intentional exposure cases increased among females, 6-17 years, during the pandemic. Findings highlight the importance of safely storing medications and being alert to signs that adolescents may be in need of mental health support services; caregivers should seek medical care or call poison control centers for any suspected poisoning event.